Rosiglitazone for Nonalcoholic Steatohepatitis

被引:0
|
作者
Dogru, Teoman [1 ]
Ercin, Cemal Nuri [1 ]
Erdem, Gokhan [2 ]
Tapan, Serkan [3 ]
Tasci, Ilker [2 ]
Sonmez, Alper [4 ]
机构
[1] Gulhane Mil Med Acad, Dept Gastroenterol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Internal Med, Ankara, Turkey
[3] Gulhane Mil Med Acad, Dept Biochem, Ankara, Turkey
[4] Gulhane Mil Med Acad, Dept Endocrinol, Ankara, Turkey
关键词
D O I
10.1053/j.gastro.2008.08.059
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2156 / 2156
页数:1
相关论文
共 50 条
  • [1] Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis
    Tahan, Veysel
    Eren, Fatih
    Avsar, Erol
    Yavuz, Dilek
    Yuksel, Meral
    Emekli, Ebru
    Imeryuz, Nese
    Celikel, Cigdem
    Uzun, Hafize
    Haklar, Goncagul
    Tozun, Nurdan
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3465 - 3472
  • [2] Rosiglitazone Attenuates Liver Inflammation in a Rat Model of Nonalcoholic Steatohepatitis
    Veysel Tahan
    Fatih Eren
    Erol Avsar
    Dilek Yavuz
    Meral Yuksel
    Ebru Emekli
    Nese Imeryuz
    Cigdem Celikel
    Hafize Uzun
    Goncagul Haklar
    Nurdan Tozun
    Digestive Diseases and Sciences, 2007, 52 : 3465 - 3472
  • [3] The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in Hunan nonalcoholic steatohepatitis
    Caldwell, Stephen H.
    Patrie, James T.
    Brunt, Elizabeth M.
    Redick, Jan A.
    Davis, Christine A.
    Park, Sang H.
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2007, 46 (04) : 1101 - 1107
  • [4] Rosiglitazone improves insulin sensitivity, ALT and hepatic steatosis in patients with nonalcoholic steatohepatitis
    Neuschwander-Tetri, BA
    Sponseller, C
    Hampton, KK
    Karadaghy, AA
    Bacon, BR
    Wehmeier, K
    Brunt, EM
    GASTROENTEROLOGY, 2002, 122 (04) : A622 - A622
  • [5] Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
    Neuschwander-Tetri, BA
    Brunt, EM
    Wehmeier, KR
    Oliver, D
    Bacon, BR
    HEPATOLOGY, 2003, 38 (04) : 1008 - 1017
  • [6] Effects of rosiglitazone on methionine-choline deficient diet-induced nonalcoholic steatohepatitis
    Tahan, Veysel
    Imeryuz, Nese
    Avsar, Erol
    Celikel, Cigdem
    Tozun, Nurian
    HEPATOLOGY, 2007, 46 (06) : 2045 - 2045
  • [7] The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats
    Liu, Su
    Wu, Han-Jun
    Zhang, Zong-Qi
    Chen, Qing
    Liu, Bin
    Wu, Jian-Ping
    Zhu, Liang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 650 (01) : 384 - 389
  • [8] Nonalcoholic steatohepatitis
    Jansen, PLM
    NETHERLANDS JOURNAL OF MEDICINE, 2004, 62 (07): : 217 - 224
  • [9] Nonalcoholic steatohepatitis
    NeuschwanderTetri, BA
    Bacon, BR
    MEDICAL CLINICS OF NORTH AMERICA, 1996, 80 (05) : 1147 - +
  • [10] Nonalcoholic Steatohepatitis
    Sachak, Taha
    Yearsley, Martha
    Levin, Douglas
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08): : 780 - 780